Monday, October 19, 1998
Can it get any worse?
If the biotech sector's fundamentals are so great, but the disinterest of the markets so deafening, the question then becomes whether the situation can get any worse.
"How do you say it's at the bottom?" asked Leonard Bell, president and CEO of Alexion Pharmaceuticals Inc. "If there's no news that can move the stock, that's one indication, and that's the situation we're in now. Liquidity is worse now than it's ever been due to lack of interest, and the degree of volatility